DuPont sees earning slide in TiO2, fluorochemicals, arm – but outlook good

By Siobhan Lismore-Scott
Published: Tuesday, 22 April 2014

While the slide in earnings in the segment which encompasses the titanium dioxide (TiO2) business is not exactly positive, an increase in volume and positive remarks from the both the CFO and CEO of DuPont mark a change as we go into Q2.

DuPont said in its Q1 results that its operating earnings fell in its performance chemical arm, which encompasses its fluorochemicals and titanium dioxide (TiO2)  business, due to lower selling prices.

"Operating earnings of $200m were down (...) 20% due...

This is a preview of the full article

  • 2 years pricing data on all minerals
  • The latest global news and features
  • Print magazine
  • Article archive ranging from 1988
  • Access on the move with IM Insight mobile app

Take a Trial or Subscription today. Start below: